In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Regitine Drug Master File in Korea (Regitine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Regitine. The MFDS reviews the Regitine KDMF as part of the drug registration process and uses the information provided in the Regitine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Regitine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Regitine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Regitine suppliers with KDMF on PharmaCompass.